NOVARTIS NNOVARTIS NNOVARTIS N

NOVARTIS N

No trades
See on Supercharts
Market capitalization
‪170.54 B‬CHF
‪13.34 B‬CHF
‪40.83 B‬CHF
‪1.75 B‬
Beta (1Y)
0.66

About NOVARTIS N

CEO
Vasant Narasimhan
Headquarters
Basel
Employees (FY)
‪76.06 K‬
Founded
1996
ISIN
CH0012005267
FIGI
BBG00HCYS021
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NOVN is 84.97 CHF — it has decreased by 1.77% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange NOVARTIS N stocks are traded under the ticker NOVN.
NOVARTIS N is going to release the next earnings report on Apr 23, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for NOVARTIS N has a max estimate of 120.03 CHF and a min estimate of 74.14 CHF.
NOVN earnings for the last quarter are 1.59 CHF whereas the estimation was 1.53 CHF which accounts for 4.37% surprise. Estimated earnings for the next quarter are 1.39 CHF. See more details about NOVARTIS N earnings.
NOVARTIS N revenue for the last quarter amounts to ‪10.79 B‬ CHF despite the estimated figure of ‪11.37 B‬ CHF. In the next quarter revenue is expected to reach ‪10.01 B‬ CHF.
Yes, you can track NOVARTIS N financials in yearly and quarterly reports right on TradingView.
Like other stocks, NOVN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS N stock right from TradingView charts — choose your broker and connect to your account.
NOVN reached its all-time high on Feb 13, 2020 with the price of 96.38 CHF, and its all-time low was 34.40 CHF and was reached on Aug 11, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪76.06 K‬ employees. See our rating of the largest employees — is NOVARTIS N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS N EBITDA is ‪19.31 B‬ CHF, and current EBITDA margin is 44.33%. See more stats in NOVARTIS N financial statements.